The Economic Burden of Disease in France From the National Health Insurance Perspective

The Healthcare Expenditures and Conditions Mapping Used to Prepare the French Social Security Funding Act and the Public Health Act

Bibliographic Data

ID9099250
AuthorsAntoine Rachas (0000-0001-9226-9071, Conservatoire National des Arts et Métiers, corresponding author), Christelle Gastaldi-Ménager, Christelle Gastaldi‐Ménager (l'Assurance Maladie), Pierre Denis (l'Assurance Maladie), Pauline Barthélémy (l'Assurance Maladie), Panayotis Constantinou (0000-0003-4023-5915, l'Assurance Maladie), Jérôme Drouin (0000-0003-2017-7041, l'Assurance Maladie), Dimitri Lastier, Thomas Lesuffleur (l'Assurance Maladie), Corinne Mette (l'Assurance Maladie), Muriel Nicolas (l'Assurance Maladie), Laurence Pestel (l'Assurance Maladie), Sébastien Rivière (0000-0001-6328-618X, l'Assurance Maladie), Ayden Tajahmady (l'Assurance Maladie), Claude Gissot (l'Assurance Maladie), Anne Fagot-Campagna, A Fagot‐Campagna (0000-0002-4125-3325, l'Assurance Maladie)
Year2022
Volume60
Issue9
Pages655-664
Publication date2022-09-01
Open AccessYes
TypeARTICLE
VenueMedical Care (JOURNAL)
Journal identifiersISSN: 0025-7079 • E-ISSN: 1537-1948
PublisherOvid Technologies (Wolters Kluwer Health) (PUBLISHER)
DOI10.1097/mlr.0000000000001745
PMID35880776
OpenAlexW4288038265
LanguageEN
Citations received3
References cited23

BACKGROUND: Identifying the most frequently treated and the costliest health conditions is essential for prioritizing actions to improve the resilience of health systems. OBJECTIVES: Healthcare Expenditures and Conditions Mapping describes the annual economic burden of 58 health conditions to prepare the French Social Security Funding Act and the Public Health Act. DESIGN: Annual cross-sectional study (2015-2019) based on the French national health database. SUBJECTS: National health insurance beneficiaries (97% of the French residents). MEASURES: All individual health care expenditures reimbursed by the national health insurance were attributed to 58 health conditions (treated diseases, chronic treatments, and episodes of care) identified by using algorithms based on available medical information (diagnosis coded during hospital stays, long-term diseases, and specific drugs). RESULTS: In 2019, €167.0 billion were reimbursed to 66.3 million people (52% women, median age: 42 y). The most prevalent treated diseases were diabetes (6.0%), chronic respiratory diseases (5.5%), and coronary diseases (3.2%). Coronary diseases accounted for 4.6% of expenditures, neurotic and mood disorders 3.7%, psychotic disorders 2.8%, and breast cancer 2.1%. Between 2015 and 2019, the expenditures increased primarily for diabetes (+€906 million) and neurotic and mood disorders (+€861 million) due to the growing number of patients. "Active lung cancer" (+€797 million) represented the highest relative increase (+54%) due to expenditures for the expensive drugs and medical devices delivered at hospital. CONCLUSIONS: These results have provided policy-makers, evaluators, and public health specialists with key insights into identifying health priorities and a better understanding of trends in health care expenditures in France

Disease · Economic growth · Environmental health · Family medicine · Health care · Public health · Global Health Care Issues · Healthcare Systems and Practices · Healthcare Systems and Reforms · Medicine · Nursing · Health Policy

Tools

Open DOIOpen Access